Company: RGNX
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0000950170-25-052069
Chunk: 67

Company: REGENXBIO Inc.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 67
---
 balance in cash, cash equivalents and marketable securities |
| - Operating expenses                                                 |
| - Revenue                                                            |

<div align='center'>48</div>

The following graphs illustrate the relationships between the compensation actually paid to our NEOs and (i) TSR, (ii) net income (loss) and (iii) ending cash, cash equivalents and marketable securities, as disclosed in the pay versus performance table above for each of the years presented.

Relationship Between Compensation Actually Paid and Total Shareholder Return

Relationship BetweenCompensation Actually Paid and Net Income (Loss)

Relationship between Compensation actually paid and cash, cash equivalents & Marketable Securities

<div align='center'>49

PROPOSAL 4:

ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON

EXECUTIVE COMPENSATION</div>

In addition to the stockholder advisory vote on executive compensation, we are also holding a stockholder advisory vote as to the frequency with which stockholders would have an opportunity to provide an advisory determination on executive compensation. Under SEC rules, this vote on frequency is required once every six years. The current frequency as voted by stockholders is annually.

For the reasons described below, we recommend that our stockholders approve the following resolution, which is to implement a frequency of every year, or an annual vote, on executive compensation.

RESOLVED, that the stockholders of REGENXBIO Inc. (the “Company”) hereby approve, on a non-binding advisory basis, an annual vote by the stockholders of the Company, on a non-binding advisory basis, on the compensation of the Company’s named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission.

Our Board believes that an annual vote on executive compensation is the best approach for the Company based on a number of considerations, including the following:

At the 2019 annual meeting, a majority of our stockholders expressed their preference that future advisory votes on executive compensation be conducted on an annual basis, and we have held such votes annually since 2019.

An annual stockholder vote allows our stockholders to provide the Company with direct and immediate feedback regarding the effectiveness of our compensation programs.

An annual stockholder vote provides our Compensation Committee with the opportunity to consider stockholder views as part of its regular compensation review.

While this vote is being conducted on an advisory basis, and is therefore not binding on us, the vote will be carefully considered by the Compensation Committee and the Board. Both the Compensation Committee and the Board value the opinions of